CoChat

Neonatal screening for congenital adrenal hyperplasia

van der Kamp, HJ, Wit, JM · 2004 · European Journal of Endocrinology

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Congenital adrenal hyperplasia (CAH) is well suited for newborn screening, as it is a common and potentially fatal disease which can be easily diagnosed by a simple hormonal measurement in blood. Moreover, early recognition and treatment can prevent severe salt wasting, dehydration and death and shorten the time of male sex assignment in virilised females.In screening programmes, 17alpha-hydroxyprogesterone (17OHP) is measured in filter paper blood spots obtained by a heel puncture preferably between 2 and 4 days after birth. Three assay techniques are utilised for initial screening: radio-immunoassay (USA), enzyme-linked immunosorbent assay (Japan) and time-resolved fluoro-immunoassay (Europe). Preterm newborns have higher 17OHP concentrations in serum than babies born at term. Therefore, cut-off levels are based on gestational age (in Japan and Europe) or on birth weight (in the USA). There is a considerable variation in cut-off levels from one programme to another. This is most likely due to the different antibodies and reagents used, varying thickness and density of filter paper used for sample collection and, most significantly, the characteristics of the reference population (in terms of birth weight and gestational age). More than 30 million newborns have been screened. The prevalence of CAH in the USA and Europe is approximately 1:15 000-16 000, and slightly lower in Japan (1:19 000). In general, severe salt wasting can be prevented, but there is a remarkable variation in the number of false-positives and false-negatives among the various programmes. Ongoing refinement of cut-off levels is needed to improve specificity and sensitivity.

Overview

Integrity signals

Registry

Crossref · 10.1530/eje.0.151u071

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 27 references

Cited by

See all 128

Metadata

Authors
van der Kamp, H., & Wit, J.
Venue
European Journal of Endocrinology
Published
2004-11-01
Volume
151 Suppl 3
Pages
U71-U75
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2118556129
Cited by
128
References
27
Citations by year
2026: 1 · 2025: 3 · 2024: 9 · 2023: 3 · 2022: 4 · 2021: 7 · 2020: 5 · 2019: 9 · 2018: 5 · 2017: 9 · 2016: 7 · 2015: 6 · 2014: 10 · 2013: 7 · 2012: 10
FWCI
0.95
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords
congenital adrenal hyperplasia, newborn screening, 17-hydroxyprogesterone, cut-off values, preterm infants, false positives, prevalence, salt wasting, radioimmunoassay, ELISA, time-resolved fluoroimmunoassay
MeSH terms
Adrenal Hyperplasia, Congenital, Enzyme-Linked Immunosorbent Assay, False Positive Reactions, Female, Humans, Immunoenzyme Techniques, Infant, Newborn, Predictive Value of Tests, Radioimmunoassay, Neonatal Screening, 17-alpha-Hydroxyprogesterone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neonatal screening for congenital adrenal hyperplasia. https://app.cochat.ai/papers/10.1530/eje.0.151u071
The paper
van der Kamp, H., & Wit, J. (2004). Neonatal screening for congenital adrenal hyperplasia. European Journal of Endocrinology. https://doi.org/10.1530/eje.0.151u071

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.